Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interactions between remimazolam and propofol with sufentanil during gastroscopy
ChiCTR2100052425Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Hainan Medical University
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam, propofol and sufentanil in gastrointestinal conditions (5 arms), sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoint: eyelash reflex. Started Jan 2021; status: completed.
02
Drugs
remimazolampropofolsufentanil
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2100052425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052425.